ÂÜÀòÂÒÂ×

Hannah Melinchuk is a manager at Clarion. Her project experiences range from early commercial opportunity assessments to complex therapeutic area and business unit strategy projects for clients ranging from small biotech to large pharma across a range of therapeutic areas. Her specific interests focus on early commercial strategy, such as opportunity assessments and indication prioritization, for products in the rare disease space. More broadly, her project experience includes opportunity assessment, indication prioritization, brand strategy, commercial due diligence, patient journey analysis, BD assessments & strategy, diagnostic strategy, therapeutic area strategy, sales force optimization, and organization structure optimization.

Hannah received a BA in Biology from Dartmouth College.